Balaji Amines Limited (BALAMINES) Price & Analysis

Compare

4 Followers

BALAMINES Stock Chart & Stats

₹1090.80

₹185.05(10.63%)

At close: Jan 09 4:00 PM EST

₹1090.80

₹185.05(10.63%)

Day’s Range― - ―

52-Week Range₹905.15 - ₹1,946.00

Previous CloseN/A

Volume2.22M

Average Volume (3M)3.13K

Market Cap

₹33.48B

Enterprise Value₹32.35B

Total Cash (Recent Filing)₹1.86B

Total Debt (Recent Filing)₹314.46M

Price to Earnings (P/E)29.5

Beta1.28

Next Earnings

May 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.97%

Share Statistics

EPS (TTM)12.20

Shares Outstanding32,401,000

10 Day Avg. Volume2,179

30 Day Avg. Volume3,132

Financial Highlights & Ratios

PEG Ratio-1.11

Price to Book (P/B)2.20

Price to Sales (P/S)2.91

P/FCF Ratio46.43

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)41.45

Revenue Forecast (FY)₹13.64B

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetA low debt-to-equity profile gives Balaji Amines durable financial flexibility to fund capex, absorb demand shocks, and pursue selective expansions without stressing liquidity. Over 2-6 months this reduces refinancing risk and preserves strategic optionality versus leveraged peers.

Positive Free Cash FlowConsistent positive free cash flow supports reinvestment in downstream integration, maintenance capex and working capital while enabling deleveraging or shareholder returns. Reliable cash generation improves resilience through cyclical industry swings and funds long-term value creation.

Diversified End-market ExposureServing multiple industrial end-markets and both domestic and export customers lowers demand concentration risk and allows the company to shift sales mix toward higher-margin derivatives. Structural diversification supports steadier revenue across industry cycles.

Bears Say

Declining RevenueA multi-percent revenue contraction signals weakening demand or lost volume that can persist without corrective strategy. Over months this limits internal cash available for growth initiatives, pressures margin recovery, and increases reliance on cost cuts to sustain profitability.

Earnings ContractionSharp EPS decline indicates margin and profit erosion beyond revenue effects, reducing retained earnings and ability to invest. Sustained earnings deterioration can constrain balance-sheet strengthening, hamper R&D or downstream integration, and weaken competitive positioning.

Input Cost And Utilization RiskHigh sensitivity to raw-material prices and plant utilization creates structural margin volatility. If feedstock inflation or underutilization persists, fixed-cost absorption weakens margins and limits returns on expansion of specialty product lines that are critical for long-term margin improvement.

Balaji Amines Limited News

Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares

Balaji Amines Limited ( ($IN:BALAMINES) ) has shared an announcement. Balaji Amines Limited has announced that it has...

10d ago

Balaji Amines Reschedules Q2FY26 Earnings Call

An update from Balaji Amines Limited ( ($IN:BALAMINES) ) is now available. Balaji Amines Limited has announced a...

4M ago

Balaji Amines Clarifies Misleading Article on Chemical Production

An update from Balaji Amines Limited ( ($IN:BALAMINES) ) is now available. Balaji Amines Limited has issued a...

5M ago

Balaji Amines Limited Submits Compliance Certificate for Q3 2025

Balaji Amines Limited ( ($IN:BALAMINES) ) has provided an announcement. Balaji Amines Limited has submitted a certificate under...

5M ago

Balaji Amines Limited Holds 37th AGM with Transparent E-voting

Balaji Amines Limited ( ($IN:BALAMINES) ) has issued an announcement. Balaji Amines Limited conducted its 37th Annual General...

7M ago

Balaji Amines Schedules Investor Meeting to Discuss Public Information

The latest update is out from Balaji Amines Limited ( ($IN:BALAMINES) ). Balaji Amines Limited has announced that...

12M ago

BALAMINES FAQ

What was Balaji Amines Limited’s price range in the past 12 months?

Balaji Amines Limited lowest stock price was ₹905.15 and its highest was ₹1946.00 in the past 12 months.

What is Balaji Amines Limited’s market cap?

Balaji Amines Limited’s market cap is ₹33.48B.

When is Balaji Amines Limited’s upcoming earnings report date?

Balaji Amines Limited’s upcoming earnings report date is May 13, 2026 which is in 60 days.

How were Balaji Amines Limited’s earnings last quarter?

Balaji Amines Limited released its earnings results on Jan 29, 2026. The company reported ₹12.2 earnings per share for the quarter, the consensus estimate of ₹12.2 by ₹0.

Is Balaji Amines Limited overvalued?

According to Wall Street analysts Balaji Amines Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Balaji Amines Limited pay dividends?

Balaji Amines Limited pays a Annually dividend of ₹11 which represents an annual dividend yield of 0.97%. See more information on Balaji Amines Limited dividends here

What is Balaji Amines Limited’s EPS estimate?

Balaji Amines Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Balaji Amines Limited have?

Balaji Amines Limited has 32,401,000 shares outstanding.

What happened to Balaji Amines Limited’s price movement after its last earnings report?

Balaji Amines Limited reported an EPS of ₹12.2 in its last earnings report, expectations of ₹12.2. Following the earnings report the stock price went down -5.893%.

Which hedge fund is a major shareholder of Balaji Amines Limited?

Currently, no hedge funds are holding shares in IN:BALAMINES

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Balaji Amines Limited

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.